Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $304.96 billion as of June 27, 2025. Its market cap has decreased by -51.70% in one year.

Market Cap

304.96B

Enterprise Value

317.08B

Revenue

43.92B

Ranking

n/a

PE Ratio

20.12

Stock Price

$68.25

Market Cap Chart

Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 304.96B, an increase of 4,167.31%. That is a compound annual growth rate of 14.15%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	299.93B	-22.26%
Dec 30, 2024	385.82B	-16.41%
Dec 29, 2023	461.55B	51.61%
Dec 30, 2022	304.43B	19.34%
Dec 30, 2021	255.09B	56.58%
Dec 30, 2020	162.91B	19.30%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Elite Pharmaceuticals	827.70M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
American Oncology Network	420.90M
CytoDyn	404.64M
Glass House Brands	389.15M

Market Cap Rankings